{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:24:36Z","timestamp":1791815076382,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.intimp.2026.116846","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:13:02Z","timestamp":1778760782000},"page":"116846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Tumor cell-derived exosomal E2F7 promotes colorectal cancer progression by interacting with SMC4 and induced macrophage M2 polarization"],"prefix":"10.1016","volume":"182","author":[{"given":"Sheng","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanmao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2026.116846_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.intimp.2026.116846_bb0010","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.dld.2023.06.010","article-title":"CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer","volume":"56","author":"Zhu","year":"2024","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.intimp.2026.116846_bb0015","article-title":"Tumor-associated macrophages (TAMs) in colorectal Cancer (CRC): from mechanism to therapy and prognosis","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116846_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","article-title":"Targeting tumor-associated macrophages to synergize tumor immunotherapy","volume":"6","author":"Xiang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.116846_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116846_bb0030","article-title":"Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116846_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047045","article-title":"The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer","volume":"7","author":"Edin","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.intimp.2026.116846_bb0040","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00384-020-03593-z","article-title":"Tumor-associated macrophage infiltration and prognosis in colorectal cancer: systematic review and meta-analysis","volume":"35","author":"Li","year":"2020","journal-title":"Int. J. Color. Dis."},{"key":"10.1016\/j.intimp.2026.116846_bb0045","article-title":"The roles of E2F7 in cancer: current knowledge and future prospects","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.intimp.2026.116846_bb0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/hep.31259","article-title":"E2F7 is a potent inhibitor of liver tumor growth in adult mice","volume":"73","author":"Moreno","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2026.116846_bb0055","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/mc.23454","article-title":"E2F7 enhances hepatocellular carcinoma growth by preserving the SP1\/SOX4\/anillin axis via repressing miRNA-383-5p transcription","volume":"61","author":"Hao","year":"2022","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.intimp.2026.116846_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109694","article-title":"Natural compound So-2 suppresses triple-negative breast cancer through inducing ferroptosis via downregulating transcription factor E2F7","volume":"744","author":"Liu","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.intimp.2026.116846_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.108027","article-title":"E2F1 and E2F7 regulate gastric cancer cell proliferation, respectively, through transcriptional activation and transcriptional repression of MYBL2","volume":"301","author":"Wu","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2026.116846_bb0070","first-page":"527","article-title":"Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer","volume":"25","author":"Kim","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.intimp.2026.116846_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2025.156049","article-title":"Exosomal circUBQLN1 facilitates M2 polarization of macrophages and enhances colorectal cancer progression by modulating the miR-34c-5p\/CSF1R axis","volume":"272","author":"Wang","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.intimp.2026.116846_bb0080","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s11010-023-04854-5","article-title":"Exosome miRNA-203 promotes M1 macrophage polarization and inhibits prostate cancer tumor progression","volume":"479","author":"Zhang","year":"2024","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2026.116846_bb0085","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2147\/OTT.S238947","article-title":"The long non-coding RNA-RoR promotes the tumorigenesis of human colorectal cancer by targeting miR-6833-3p through SMC4","volume":"13","author":"Li","year":"2020","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.intimp.2026.116846_bb0090","doi-asserted-by":"crossref","DOI":"10.1177\/03946320241286565","article-title":"SMC4 serves as a potential marker for the diagnosis and prognosis of colon adenocarcinoma","volume":"38","author":"Yang","year":"2024","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.intimp.2026.116846_bb0095","article-title":"SMC4, a novel tumor prognostic marker and potential tumor therapeutic target","volume":"13","author":"Zhao","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.116846_bb0100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.116846_bb0105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12943-019-0976-4","article-title":"Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis","volume":"18","author":"Wei","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.intimp.2026.116846_bb0110","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4014\/jmb.2103.03001","article-title":"LINC00174 facilitates proliferation and migration of colorectal Cancer cells via MiR-3127-5p\/ E2F7 Axis","volume":"31","author":"Ma","year":"2021","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.intimp.2026.116846_bb0115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.18632\/aging.204503","article-title":"Association of SMC4 with prognosis and immune infiltration of sarcoma","volume":"15","author":"Jiang","year":"2023","journal-title":"Aging (Albany NY)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926006922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926006922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:03:11Z","timestamp":1789243391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926006922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"alternative-id":["S1567576926006922"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116846","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor cell-derived exosomal E2F7 promotes colorectal cancer progression by interacting with SMC4 and induced macrophage M2 polarization","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116846"}}